• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2025 Elections
  • Government Shutdown
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Benjamin Brafman, right, attorney for pharmaceutical chief Martin Shkreli, foreground, speaks on Capitol Hill on Feb. 4 during a House Committee on Oversight and Reform Committee hearing on rising drug prices. Shkreli refused to testify before U.S. lawmakers who excoriated him over severe hikes for a drug sold by a company that he acquired. (AP Photo/Susan Walsh)
    Healthcare

    Lawmakers feel the pain over drug prices

    Paige Winfield Cunningham -
    June 6, 2016 4:01 am
    0
    Former drug company CEO Martin Shrkeli has been hit with a new conspiracy charge. (AP Photo/Craig Ruttle)
    Crime

    ‘Pharma Bro’ slapped with another charge

    Daniel Chaitin -
    June 4, 2016 5:03 pm
    0
    The agency on Thursday finalized a rule that streamlines the process of applying for compassionate use, which enables a patient to get non-approved treatments when there isn’t any other option. (iStock photo)
    Healthcare

    FDA speeds up process of applying for last resort drugs

    Robert King -
    June 2, 2016 2:57 pm
    0
    Rep. Mike Bishop, R-Mich., said Wednesday the administration hasn't answered his questions about why it didn't grant emergency funds to victims in a 2012 outbreak of meningitis. (AP Photo/Susan Walsh, File)
    Healthcare

    Lawmaker wants funds for victims of tainted drug scandal

    Robert King -
    June 1, 2016 2:50 pm
    0
    Republicans want the Obama administration to allow drug firms to advertise unapproved drug uses to doctors. (AP Photo/Sue Ogrocki, File)
    Healthcare

    House lawmakers push HHS on drug advertising

    Robert King -
    May 26, 2016 10:58 pm
    0
    The Food and Drug Administration approved Probuphine, which is an implant intended to provide a low-level dose of the opioid addiction treatment buprenorphine. (Screenshot)
    Healthcare

    FDA approves new way to fight opioid addiction

    Robert King -
    May 26, 2016 9:29 pm
    0
    The FDA is putting off a decision on whether to approve a controversial drug that patient advocates and some senators say is the only hope for children with Duchenne Muscular Dystrophy. (iStock Photo)
    Healthcare

    FDA delays decision on controversial drug

    Robert King -
    May 25, 2016 4:16 pm
    0
    Two Republican senators, including Wisconsin Sen. Ron Johnson, are disappointed that a panel of experts did not recommend a new drug called Sarepta for Duchenne muscular dystrophy, a fatal disease that mainly affects young boys. (AP Photo/Susan Walsh, File)
    Healthcare

    Senators push FDA to approve drug for rare disease

    Robert King -
    May 23, 2016 10:15 pm
    0
    A majority of Americans don't want to sacrifice safety in exchange for getting new treatments faster to the market, a new poll finds. (AP Photo/Andrew Welsh-Huggins)
    Healthcare

    Americans prioritize safety over speedy drug approval, poll finds

    Robert King -
    May 11, 2016 2:51 pm
    0
    AARP said in comments on the proposed rule that were due Monday that seniors need relief from high drug prices. (FILE Bloomberg/Tannen Maury)
    Healthcare

    Drug industry, AARP fight over Medicare changes

    Robert King -
    May 10, 2016 4:01 am
    0
    1...116117118...151Page 117 of 151
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.